Heidi J. Gray, MD
22 Years of Experience
Top Doctor
The Top Doctor award is a peer-nominated award for providers who give exceptional care.
Physician
Seattle Cancer Care Alliance
Seattle Cancer Care Alliance
Professor, Division of Gynecologic Oncology
University of Washington School of Medicine
University of Washington School of Medicine
Director, Gynecologic Oncology Fellowship Program
UW Medicine
UW Medicine
Affiliate Investigator
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Clinical expertise
Gynecologic oncology
Gynecologic oncology
Located at
Clinical expertise
Gynecologic Oncology
Gynecologic Oncology
Medical Degree
University of California, Los Angeles
University of California, Los Angeles
Residency
University of Washington, Obstetrics & Gynecology
University of Washington, Obstetrics & Gynecology
Fellowship
University of Pennsylvania, Gynecologic Oncology
University of Pennsylvania, Gynecologic Oncology
Board Certification
Gynecologic Oncology, 2007; Obstetrics & Gynecology, 2005, American Board of Obstetrics & Gynecology
Gynecologic Oncology, 2007; Obstetrics & Gynecology, 2005, American Board of Obstetrics & Gynecology
Languages
English
Your care team
At SCCA, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a team coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
Registered nurse (RN)
Your nurse manages your care alongside your physician and assists with care procedures and
treatments.
Team coordinator (TC)
Your team coordinator works closely with you and your physician and serves as your scheduler.
Clinical trials
We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.
Cediranib Maleate and Olaparib or Standard Chemotherapy in Treating Patients With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
Study No:
NCT02502266
Phase:
Phase II/III
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy
Study No:
NCT00980954
Phase:
Phase III
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Study No:
NCT02713386
Phase:
Phase I/II
A Study of RO7198457 (Personalized Cancer Vaccine [PCV]) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
Study No:
NCT03289962
Phase:
Phase I
Publications
Many of our SCCA physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this SCCA provider has written.
A phase I study of intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer.